Abstinence Period for Male Infertility
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Abstinence Period for Male Infertility is an effective treatment?
The available research shows that a short period of abstinence before procedures like intrauterine insemination is linked to higher pregnancy rates. Another study found that the abstinence period can affect fertilization outcomes in certain fertility treatments. Additionally, for men with severe infertility, adjusting the abstinence period can improve outcomes when using assisted reproductive technologies. However, the impact of abstinence on sperm quality can vary, and some studies suggest that shorter abstinence might be better for certain conditions.12345
What safety data exists for abstinence periods in male infertility treatment?
The research suggests that ejaculatory abstinence can impact semen parameters and reproductive outcomes. Studies have explored its effects on pregnancy rates, fertilization outcomes in ICSI cycles, and sperm quality. However, the influence of abstinence on sperm integrity and clinical success is still debated, indicating a need for further investigation to fully understand its safety and efficacy.12456
Is the treatment 'Abstinence Period for Male Infertility' a promising treatment?
What is the purpose of this trial?
The goal of this study is to learn about the impact of abstinence periods on sperm quality in healthy males 20-45 years of age with no significant comorbidities who are able to produce a semen sample via masturbation. The main question it aims to answer is:• Do shorter abstinence periods result in improved semen quality?Participants will provide semen samples for analysis following abstinence periods of 7 days, 5 days, 2 days, 1 day, and 3 hours.
Research Team
Jonathan Gal, MD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for healthy men aged 20-45 who can provide a semen sample and have a sperm count of at least 1 million with high DNA fragmentation. It's not for those with low sperm counts, normal DNA fragmentation, significant health issues, or no semen production.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Sample Collection
Participants provide semen samples following abstinence periods of 7 days, 5 days, 2 days, 1 day, and 3 hours
Data Analysis
Analysis of semen parameters and sperm DNA fragmentation after varying abstinence periods
Treatment Details
Interventions
- Abstinence
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor